Unichem Laboratories Limited (UNICHEMLAB.BO)
INR 743.95
(-2.17%)
INR 743.95
(-2.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.86 Billion INR | -27.06% |
| 2022 | 7.32 Billion INR | -9.33% |
| 2021 | 8.07 Billion INR | 2.4% |
| 2020 | 7.88 Billion INR | 23.26% |
| 2019 | 6.39 Billion INR | -2.41% |
| 2018 | 6.55 Billion INR | 62.62% |
| 2017 | 4.03 Billion INR | -0.27% |
| 2016 | 4.04 Billion INR | -53.17% |
| 2015 | 8.63 Billion INR | 15.21% |
| 2014 | 7.49 Billion INR | 1.45% |
| 2013 | 7.38 Billion INR | 9.14% |
| 2012 | 6.76 Billion INR | 20.78% |
| 2011 | 5.6 Billion INR | 10.16% |
| 2010 | 5.08 Billion INR | -31.95% |
| 2009 | 7.47 Billion INR | 1.65% |
| 2008 | 7.35 Billion INR | 9.52% |
| 2007 | 6.71 Billion INR | 6.91% |
| 2006 | 6.27 Billion INR | 14.74% |
| 2005 | 5.47 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.59 Billion INR | 15.05% |
| 2023 Q4 | 1.38 Billion INR | -2.6% |
| 2023 FY | 5.33 Billion INR | -27.06% |
| 2023 Q1 | 2.54 Billion INR | 50.96% |
| 2023 Q2 | 2.52 Billion INR | -0.75% |
| 2023 Q3 | 1.41 Billion INR | -43.87% |
| 2022 Q4 | 1.68 Billion INR | 2.47% |
| 2022 Q1 | 1.99 Billion INR | -11.43% |
| 2022 Q2 | 1.99 Billion INR | -0.02% |
| 2022 Q3 | 1.64 Billion INR | -17.37% |
| 2022 FY | 7.32 Billion INR | -9.33% |
| 2021 Q3 | 2.01 Billion INR | 4.76% |
| 2021 FY | 8.07 Billion INR | 2.4% |
| 2021 Q4 | 2.25 Billion INR | 11.42% |
| 2021 Q2 | 1.92 Billion INR | 2.81% |
| 2021 Q1 | 1.87 Billion INR | 27.38% |
| 2020 Q2 | 2.19 Billion INR | 9.9% |
| 2020 Q3 | 2.22 Billion INR | 1.54% |
| 2020 Q4 | 1.47 Billion INR | -33.85% |
| 2020 Q1 | 1.99 Billion INR | 30.15% |
| 2020 FY | 7.88 Billion INR | 23.26% |
| 2019 Q4 | 1.53 Billion INR | -17.25% |
| 2019 Q3 | 1.85 Billion INR | 13.31% |
| 2019 Q2 | 1.63 Billion INR | -4.35% |
| 2019 Q1 | 1.7 Billion INR | -7.26% |
| 2019 FY | 6.39 Billion INR | -2.41% |
| 2018 FY | 6.55 Billion INR | 62.62% |
| 2018 Q4 | 1.84 Billion INR | -6.82% |
| 2018 Q3 | 1.97 Billion INR | 45.85% |
| 2018 Q2 | 1.35 Billion INR | -1.65% |
| 2018 Q1 | 1.37 Billion INR | 63.12% |
| 2017 FY | 4.03 Billion INR | -0.27% |
| 2017 Q4 | 845.15 Million INR | 0.0% |
| 2016 Q4 | 6.71 Billion INR | 0.0% |
| 2016 FY | 4.04 Billion INR | -53.17% |
| 2015 FY | 8.63 Billion INR | 15.21% |
| 2014 FY | 7.49 Billion INR | 1.45% |
| 2013 FY | 7.38 Billion INR | 9.14% |
| 2012 FY | 6.76 Billion INR | 20.78% |
| 2011 FY | 5.6 Billion INR | 10.16% |
| 2010 FY | 5.08 Billion INR | -31.95% |
| 2009 FY | 7.47 Billion INR | 1.65% |
| 2008 FY | 7.35 Billion INR | 9.52% |
| 2007 FY | 6.71 Billion INR | 6.91% |
| 2006 FY | 6.27 Billion INR | 14.74% |
| 2005 FY | 5.47 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | 76.904% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -212.549% |
| Sigachi Industries Limited | 2 Billion INR | -142.969% |
| Bal Pharma Limited | 770.19 Million INR | -531.649% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 21.462% |
| Medico Remedies Limited | 262.14 Million INR | -1755.824% |
| Lasa Supergenerics Limited | 121.02 Million INR | -3919.608% |
| Venus Remedies Limited | 2.18 Billion INR | -122.898% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 907.583% |
| Alpa Laboratories Limited | 188.89 Million INR | -2475.468% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -63.689% |
| Shilpa Medicare Limited | 3.54 Billion INR | -37.162% |
| Aarti Drugs Limited | 8.31 Billion INR | 41.501% |
| Lupin Limited | 123.71 Billion INR | 96.068% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 96.855% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 96.115% |
| Windlas Biotech Limited | 1.33 Billion INR | -263.38% |
| Suven Life Sciences Limited | -200.79 Million INR | 2522.811% |
| Eris Lifesciences Limited | 10.42 Billion INR | 53.342% |
| Valiant Laboratories Limited | -60.66 Million INR | 8119.47% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 78.568% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -464.901% |
| Ipca Laboratories Limited | 29.8 Billion INR | 83.68% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -31.647% |
| Achyut Healthcare Limited | 4.86 Million INR | -99980.868% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.118% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -230.542% |
| RPG Life Sciences Limited | 2.48 Billion INR | -95.93% |
| Mankind Pharma Limited | 44.52 Billion INR | 89.073% |
| Laurus Labs Limited | 24.62 Billion INR | 80.24% |
| Piramal Pharma Limited | 24.47 Billion INR | 80.12% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -416.228% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 89.595% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 81.834% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 92.984% |
| Sequent Scientific Limited | 2.97 Billion INR | -63.322% |
| Novartis India Limited | 1.32 Billion INR | -266.639% |
| Wanbury Limited | 1.73 Billion INR | -181.105% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -17.987% |
| Wockhardt Limited | 16.24 Billion INR | 70.044% |
| Themis Medicare Limited | 1.5 Billion INR | -223.487% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -645.48% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 75.233% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 60.871% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 97.026% |
| Divi's Laboratories Limited | 32.44 Billion INR | 85.003% |
| NATCO Pharma Limited | 25.73 Billion INR | 81.097% |
| Gufic Biosciences Limited | 4.16 Billion INR | -16.729% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -6.203% |
| Ind-Swift Limited | 2.17 Billion INR | -123.929% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 15.852% |
| FDC Limited | 8.33 Billion INR | 41.631% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -2424.26% |
| Granules India Limited | 16.79 Billion INR | 71.041% |
| Medicamen Biotech Limited | 495.49 Million INR | -881.833% |
| Alkem Laboratories Limited | 52.29 Billion INR | 90.697% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 21.82% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -33267.84% |
| Brooks Laboratories Limited | 65.62 Million INR | -7313.793% |
| Megasoft Limited | 342.07 Million INR | -1322.199% |
| ZIM Laboratories Limited | 1.26 Billion INR | -284.007% |
| Strides Pharma Science Limited | 14.38 Billion INR | 66.188% |
| Neuland Laboratories Limited | 8.24 Billion INR | 41.016% |
| Morepen Laboratories Limited | 6.16 Billion INR | 21.04% |
| Hikal Limited | 3.14 Billion INR | -54.782% |
| Indoco Remedies Limited | 6.04 Billion INR | 19.472% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 16.573% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -684.063% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -591.429% |
| Hester Biosciences Limited | 1.27 Billion INR | -281.968% |